Thyroid/Endocrine – Phase II Study of Cabozantinib in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Who Progressed on Prior VEGFR-Targeted Therapy

Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer »